Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions.

Saved in:
Bibliographic Details
Title: Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions.
Authors: Wang Z; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, PR China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China., Cheng G; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, PR China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China., Guo W; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, PR China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China., Chen H; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, PR China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China., Zhou Z; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, PR China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China., Shi R; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Gao H; Department of Pharmacy, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China., Li H; Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China., Tu J; Second Clinical Medical College, Hainan Medical University, Haikou, 571199, China., Chen W; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, PR China.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China., Yang S; Department of Pediatric Urology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, PR China., Qin H; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China., Zuo L; Center of Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China., Lu Q; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China. christy_luq@csu.edu.cn., Xu R; Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, PR China. xuran@csu.edu.cn.; National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China. xuran@csu.edu.cn.
Source: Biomarker research [Biomark Res] 2026 Feb 28; Vol. 14 (1). Date of Electronic Publication: 2026 Feb 28.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2050-7771
DOI:10.1186/s40364-026-00895-2